Skip to content
About
Clinical Trials
Resources
Contact
About
Clinical Trials
Resources
Contact
NSABP B61
Phase III study of adjuvant giredestrant in estrogen receptor positive HER2-negative early breast cancer:
Status:
Open
Trial Type:
Breast Cancer
Contact:
William Sikov, MD
wsikov@wihri.org
